Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.385
-0.055 (-3.82%)
Nov 19, 2026, 4:00 PM EST - Market closed
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $77.3 million as of November 19, 2026. It is the 26,390th most valuable company in the world and the 4,209th biggest in the United States. Its market cap has decreased by 30.02% in one year.
Market Cap
77.30M
Enterprise Value
-56.85M
1-Year Change
-30.02%
Global Rank
Country Rank
#4,209 United States
Category
ChartMarket Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $3.27B to $77.30M, a decrease of -97.64%. That is a compound annual growth rate of -46.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 77.30M | -24.90% |
| Dec 31, 2025 | 102.94M | -24.43% |
| Dec 31, 2024 | 136.21M | 10.01% |
| Dec 29, 2023 | 123.82M | -65.92% |
| Dec 30, 2022 | 363.32M | -74.19% |
| Dec 31, 2021 | 1.41B | -57.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Black Diamond Therapeutics | 87.93M |
| Nkarta | 86.76M |
| Genelux | 86.04M |
| TuHURA Biosciences | 84.76M |
| Polaryx Therapeutics | 83.24M |
| Rallybio | 83.05M |
| Cellectis | 80.02M |
| Tenax Therapeutics | 79.34M |